niacinamide has been researched along with Choroid Neovascularization in 7 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "SIRT1 was expressed more frequently in choroidal neovascularization membranes than donor eyes about vascular endothelial cells (78 vs." | 1.39 | Expression of SIRT1 in choroidal neovascular membranes. ( Antecka, E; Burnier, MN; Fernandes, B; Granner, T; Lim, LA; Maloney, SC; Orellana, ME, 2013) |
| "Sorafenib-treated rats had significantly less fluorescence leakage as compared with vehicle-treated rats (P < 0." | 1.36 | Effect of sorafenib on experimental choroidal neovascularization in the rat. ( Lee, YC; Park, YH; Roh, SY, 2010) |
| "Sorafenib or vehicle was administered orally to female C57BL/6 mice at the onset (day 0) of experiments." | 1.35 | Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib. ( Byeon, SH; Chung, EJ; Koh, HJ; Lee, JH; Lim, HJ; Yoo, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, JL | 1 |
| Xi, Y | 1 |
| Liu, YL | 1 |
| Wang, ZH | 1 |
| Zhang, Q | 1 |
| Rho, CR | 1 |
| Kang, S | 1 |
| Park, KC | 1 |
| Yang, KJ | 1 |
| Choi, H | 1 |
| Cho, WK | 1 |
| Morooka, S | 1 |
| Hoshina, M | 1 |
| Kii, I | 1 |
| Okabe, T | 1 |
| Kojima, H | 1 |
| Inoue, N | 1 |
| Okuno, Y | 1 |
| Denawa, M | 1 |
| Yoshida, S | 1 |
| Fukuhara, J | 1 |
| Ninomiya, K | 1 |
| Ikura, T | 1 |
| Furuya, T | 1 |
| Nagano, T | 1 |
| Noda, K | 1 |
| Ishida, S | 1 |
| Hosoya, T | 1 |
| Ito, N | 1 |
| Yoshimura, N | 1 |
| Hagiwara, M | 1 |
| Chung, EJ | 1 |
| Yoo, S | 1 |
| Lim, HJ | 1 |
| Byeon, SH | 1 |
| Lee, JH | 1 |
| Koh, HJ | 1 |
| Park, YH | 1 |
| Roh, SY | 1 |
| Lee, YC | 1 |
| Maloney, SC | 1 |
| Antecka, E | 1 |
| Granner, T | 1 |
| Fernandes, B | 1 |
| Lim, LA | 1 |
| Orellana, ME | 1 |
| Burnier, MN | 1 |
| Kernt, M | 1 |
| Staehler, M | 1 |
| Stief, C | 1 |
| Kampik, A | 1 |
| Neubauer, AS | 1 |
7 other studies available for niacinamide and Choroid Neovascularization
| Article | Year |
|---|---|
Combination of targeted PDT and anti-VEGF therapy for rat CNV by RGD-modified liposomal photocyanine and sorafenib.
Topics: Animals; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Fundus Oculi | 2013 |
Antiangiogenic effects of topically administered multiple kinase inhibitor, motesanib (AMG 706), on experimental choroidal neovascularization in mice.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Choroid; Choroidal Neovascularization; Fl | 2015 |
Identification of a Dual Inhibitor of SRPK1 and CK2 That Attenuates Pathological Angiogenesis of Macular Degeneration in Mice.
Topics: Administration, Topical; Animals; Casein Kinase II; Cell Line; Choroidal Neovascularization; Crystal | 2015 |
Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Benzenesulfonates; Blotting, Western; Choroi | 2009 |
Effect of sorafenib on experimental choroidal neovascularization in the rat.
Topics: Animals; Benzenesulfonates; Choroidal Neovascularization; Computer Systems; Disease Progression; Dos | 2010 |
Expression of SIRT1 in choroidal neovascular membranes.
Topics: Aged; Aged, 80 and over; Cells, Cultured; Choroidal Neovascularization; Cytokines; Endothelium, Vasc | 2013 |
Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment.
Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Choroidal Neovasc | 2008 |